Jun 13, 2025 3:02 AM
BACK TO TOP
KSE100
124,093.12
-259.56
(-0.21%)
ALLSHR
77,106.29
-221.51
(-0.29%)
KSE30
37,536.68
-95.15
(-0.25%)
KMI30
184,370.68
-1061.53
(-0.57%)
BKTI
30,369.22
57.60
(0.19%)
OGTI
27,659.36
-295.77
(-1.06%)
KMIALLSHR
53,011.14
-164.22
(-0.31%)
PSXDIV20
47,084.53
-243.62
(-0.51%)
UPP9
39,865.27
-81.59
(-0.20%)
NITPGI
30,751.76
-74.05
(-0.24%)
NBPPGI
33,161.35
-138.58
(-0.42%)
MZNPI
22,446.52
-215.60
(-0.95%)
JSMFI
35,170.10
61.58
(0.18%)
ACI
20,000.75
17.15
(0.09%)
JSGBKTI
36,657.76
-152.98
(-0.42%)
MII30
16,921.85
-63.44
(-0.37%)
HBLTTI
16,822.06
11-06-2025
6.45
(0.04%)
Descon Oxychem Limited
CHEMICAL
Rs.30.70
-1.14
(-3.58%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Jun 12, 2025 3:46 PM
REG
FUT
ODL
Open
32.00
High
32.90
Low
30.40
Volume
4,991,619
CIRCUIT BREAKER
28.66 — 35.02
DAY RANGE
30.40 — 32.90
52-WEEK RANGE
18.75 — 37.05
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
31.84
VAR
16.50
HAIRCUT
22.50
P/E Ratio (TTM) **
7.26
1-Year Change *
53.65%
YTD Change *
18.81%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

The Company was incorporated in Pakistan as a private limited Company on November 12, 2004 under the Companies Ordinance, 1984 (now the Companies Act, 2017) and was converted into a public limited company with effect from February 28, 2008 as approved by the Securities and Exchange Commission of Pakistan (SECP). The Company is principally engaged in manufacture, procurement and sale of hydrogen peroxide and allied products. The Company commenced its trial production on December 1, 2008 and commercial production on March 1, 2009.

KEY PEOPLE
Muhammad Mohsin ZiaCEO
Faisal DawoodChairperson
Abdul SohailCompany Secretary
ADDRESS

18 Km Ferozepur Road Lahore, Pakistan.

WEBSITE

www.desconoxychem.com

REGISTRAR

M/s Corplink (Pvt.) Limited Wings Arcade, 1-K Commercial Area, Model Town, Lahore.

AUDITOR

M/s. Crowe Hussain Chadhury & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
5,373,454.28
Shares
175,031,084
Free Float
52,509,325
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2025Transmission of Quarterly Report for the Period Ended 2025-03-31 View   PDF
Apr 30, 2025Financial Results for the Quarter Ended 31-03-2025 View   PDF
Feb 28, 2025Transmission of Quarterly Report for the Period Ended 31-12-2024 View   PDF
Feb 19, 2025Financial Results for the Quarter Ended 31-12-2024 View   PDF
Dec 2, 2024Corporate Briefing Session for the Financial Year Ended June 30, 2024 View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 17, 2024Financial Results for the Quarter Ended 30-09-2024 View   PDF
Sep 25, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
Sep 9, 2024Financial Results for the Year Ended 30-06-2024 View   PDF
Apr 30, 2024Transmission of Quarterly Report for the Period Ended 31-03-2024 View   PDF
DateTitleDocument
Apr 23, 2025Board Meetings View   PDF
Feb 18, 2025Board Meeting In Progress View   PDF
Feb 10, 2025Board Meeting View   PDF
Oct 21, 2024Resolutions passed at the 20th Annual General Meeting of Descon Oxychem Ltd View   PDF
Oct 9, 2024Board Meeting View   PDF
Sep 18, 2024Notice of Annual General Meeting View   PDF
Sep 6, 2024Board Meeting In Progress View   PDF
Aug 29, 2024Board Meeting View   PDF
Apr 8, 2024Board Meeting View   PDF
Feb 2, 2024Board Meeting View   PDF
DateTitleDocument
Mar 19, 2025Credit of Interim Cash Dividend View   PDF
Feb 21, 2025Additional Statemnets View   PDF
Feb 20, 2025Additional Statemnets View   PDF
Dec 2, 2024Flyar Corporate Briefing Session June 2024 View   PDF
Oct 29, 2024Credit of Final Dividend Warrants View   PDF
Oct 30, 2023Credit of Final Cash Dividend View   PDF
May 2, 2023Material Information View   PDF
Mar 27, 2023Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 3, 2023Credit of Interim Cash Dividend View   PDF
Feb 28, 2023APPOINTMENT OF CHAIRMAN AND CEO OF THE COMPANY View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales5,694,0896,721,3464,250,4932,804,903
Profit after Taxation471,0391,400,634470,877278,703
EPS2.698.002.691.59
Q3 2025Q2 2025Q1 2025Q3 2024
Sales1,421,2331,656,2331,498,7591,443,470
Profit after Taxation219,306261,989175,650120,473
EPS1.251.501.000.69
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)19.5541.0125.9221.85
Net Profit Margin (%)8.2720.8411.089.94
EPS Growth (%)(66.37)197.4069.18(38.37)
PEG(0.13)0.020.08(0.44)

Payouts

DateFinancial ResultsDetailsBook Closure
February 19, 2025 3:35 PM31/12/2024(HYR) 20%(i) (D) 05/03/2025 - 07/03/2025
September 9, 2024 4:00 PM30/06/2024(YR) 20%(F) (D) 10/10/2024 - 16/10/2024
September 8, 2023 4:12 PM30/06/2023(YR) 20%(F) (D) 12/10/2023 - 18/10/2023
February 14, 2023 3:17 PM31/12/2022(HYR) 20%(i) (D) 21/02/2023 - 23/02/2023
September 8, 2022 3:59 PM30/06/2022(YR) 20%(F) (D) 12/10/2022 - 20/10/2022
September 8, 2021 3:18 PM30/06/2021(YR) 10%(F) (D) 18/10/2021 - 25/10/2021
September 3, 2020 4:12 PM30/06/2020(YR) 10%(F) (D) - 16% (B) 13/10/2020 - 21/10/2020
February 14, 2019 2:22 PM31/12/2018(HYR) 10%(i) (D) 07/03/2019 - 14/03/2019
August 16, 2018 9:38 AM30/06/2018(YR) 12% (P) 15/10/2018 - 23/10/2018
April 23, 2015 5:05 PM30/06/2012(YR) 100% PREFERENCE AT PAR (R) -

Financial Reports